Heparin Cofactor II in Atherosclerotic Lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study

Heparin cofactor II (HCII) is a serine protease inhibitor (serpin) that has been shown to be a predictor of decreased atherosclerosis in the elderly and protective against atherosclerosis in mice. HCII inhibits thrombin in vitro and HCII-thrombin complexes have been detected in human plasma. Moreove...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Rau, Jill C., Deans, Carolyn, Hoffman, Maureane R., Thomas, David B., Malcom, Gray T., Zieske, Arthur W., Strong, Jack P., Koch, Gary G., Church, Frank C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783423/
https://ncbi.nlm.nih.gov/pubmed/19747479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yexmp.2009.09.003
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi